# Lucio Phenomenon

> Lucio phenomenon for NEET-PG Dermatology covers necrotising vasculitis in diffuse lepromatous leprosy, how it differs from ENL and its urgent management.

- Canonical URL: https://prepelephant.com/topics/neet-pg/dermatology/lucio-phenomenon
- Exam / course: NEET-PG · Subject: Dermatology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-15
- Last updated: 2026-10-15
- Reference basis: Rook's Textbook of Dermatology; IADVL Textbook of Dermatology; Fitzpatrick's Dermatology
- How to cite: "Lucio Phenomenon", PrepElephant, https://prepelephant.com/topics/neet-pg/dermatology/lucio-phenomenon

## Direct answer

Lucio phenomenon is a rare, severe necrotising vasculitis of small dermal vessels that occurs in diffuse lepromatous leprosy, a non-nodular form of lepromatous disease. It produces painful, haemorrhagic infarcts that ulcerate, often with fever and systemic illness. It was first recognised in Mexico, and it is treated as an urgent medical problem, with multidrug therapy, systemic steroids and wound care, although the response is variable.

## What you must remember

- **Setting:** diffuse lepromatous leprosy (DLL), reported mainly from Mexico and Central America where it was first described.
- **Skin background:** a diffusely infiltrated, non-nodular skin with a shiny appearance and loss of eyebrow hair in the lepromatous patient.
- **Hallmark lesion:** painful purpuric macules that turn haemorrhagic and necrotic, leaving infarct-like ulcers.
- **Histology:** necrotising vasculitis of small dermal vessels with thrombosis and infarction, with abundant bacilli in the lesion.
- **Systemic features:** fever and malaise commonly accompany the skin lesions.
- **Main complications:** secondary infection and deep ulceration, with scarring left behind.
- **Management:** urgent multidrug therapy, systemic corticosteroids and supportive wound care, with variable response.
- **Key distinction:** it lacks the tender nodules of erythema nodosum leprosum and shows vessel necrosis and thrombosis rather than a neutrophilic panniculitis.

## Lucio phenomenon compared with ENL

Both conditions occur in lepromatous patients and both need prompt treatment, which is why they are often confused. The table separates them by form, lesion, histology and response to treatment.

| Feature | Erythema nodosum leprosum | Lucio phenomenon |
|---|---|---|
| Leprosy form | Lepromatous and borderline lepromatous | Diffuse lepromatous leprosy |
| Lesions | Tender, erythematous subcutaneous nodules | Painful purpuric, haemorrhagic and necrotic infarcts |
| Histology | Neutrophilic infiltrate with panniculitis and foamy macrophages | Necrotising vasculitis of small dermal vessels |
| Mechanism | Immune complex deposition | Vessel occlusion with thrombosis, with bacilli implicated |
| Steroid response | Usually good | Variable |
| Course | Recurrent crops of nodules | Rapid necrosis that may ulcerate and scar |
| Tissue affected | Dermis and subcutaneous fat | Dermis and small blood vessels |
| Main risks | Neuritis, iritis and orchitis | Ulceration, secondary infection and scarring |

Histology and lesion morphology are the most reliable distinctions in an exam, whereas the response to steroids is less predictable in Lucio phenomenon. A patient suspected of Lucio phenomenon needs urgent specialist review rather than routine outpatient care. Because the necrosis can extend quickly, early wound assessment and close monitoring of fever and secondary infection form part of the initial plan.

## Where the exam tries to catch you

Most traps involve confusing Lucio phenomenon with ENL or assuming that steroids reliably control it.

- **Trap:** treating Lucio phenomenon as a nodular ENL episode — **Correct:** the lesions are necrotising vasculitis without nodules, so the histology and course differ from ENL.
- **Trap:** assuming steroids reliably control it — **Correct:** the response to steroids is variable, so urgent multidrug therapy and supportive care are central.
- **Trap:** linking it to tuberculoid leprosy — **Correct:** it occurs in diffuse lepromatous leprosy, where the bacillary load is very high.
- **Trap:** dismissing purpura in a lepromatous patient — **Correct:** painful purpuric lesions that turn haemorrhagic and necrotic need prompt review for Lucio phenomenon.

## Frequently asked questions

### What is the Lucio phenomenon in leprosy?
Lucio phenomenon is a severe necrotising vasculitis of small dermal vessels that occurs in diffuse lepromatous leprosy. It causes painful haemorrhagic infarcts that ulcerate and need urgent treatment.

### Where is the Lucio phenomenon most commonly reported?
The Lucio phenomenon is reported mainly from Mexico and Central America, where it was first described. It is rare in most other parts of the world.

### How does the Lucio phenomenon differ from erythema nodosum leprosum?
The Lucio phenomenon shows necrotising vasculitis of small vessels with haemorrhagic ulcers and no nodules. Erythema nodosum leprosum shows tender nodules with a neutrophilic infiltrate and panniculitis and responds more predictably to steroids.

### What is the management of the Lucio phenomenon?
The Lucio phenomenon is managed with urgent multidrug therapy, systemic corticosteroids and supportive wound care. Because the response to steroids is variable, the treatment plan is individualised, and books differ on the best adjuvant therapy.